GBM TME exhibits a distinct immune profile, including a high density of immune cells and elevated expression of immune checkpoint molecules such as programmed cell death protein-1 (PD−1) and its ligand PD−L1 [6,7]. This evidence concerns the gene PDCD1 and glioblastoma.